Cort 108297
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
261 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Knee osteoarthritis | D020370 | EFO_0004616 | M17 | 1 | — | 1 | 1 | 2 | 5 |
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | 1 | 1 | — | 1 | 1 | 4 |
| Adrenal insufficiency | D000309 | — | — | — | — | 1 | 2 | 1 | 4 |
| Trigger finger disorder | D052582 | — | M65.3 | — | — | — | 1 | 3 | 4 |
| Tendinopathy | D052256 | EFO_1001434 | M77.9 | — | — | — | 1 | 2 | 3 |
| Adrenocortical hyperfunction | D000308 | EFO_1000797 | — | — | 1 | — | 1 | 1 | 3 |
| Anemia | D000740 | EFO_0004272 | D64.9 | 1 | — | 1 | 1 | — | 3 |
| Shoulder pain | D020069 | — | M25.51 | — | 1 | — | 1 | 1 | 3 |
| Nervous system diseases | D009422 | — | G00-G99 | — | 1 | — | 1 | — | 2 |
| Hyperplasia | D006965 | EFO_0000536 | — | — | 1 | — | 1 | — | 2 |
Show 27 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Leukemia | D007938 | — | C95 | 14 | 26 | 17 | — | 1 | 51 |
| Lymphoma | D008223 | — | C85.9 | 19 | 30 | 10 | — | — | 48 |
| Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 11 | 26 | 16 | — | 1 | 47 |
| Lymphoid leukemia | D007945 | — | C91 | 11 | 26 | 15 | — | 1 | 46 |
| Prostatic neoplasms | D011471 | — | C61 | 4 | 25 | 3 | — | — | 29 |
| B-cell lymphoma | D016393 | — | — | 12 | 17 | 3 | — | — | 26 |
| Large b-cell lymphoma diffuse | D016403 | — | C83.3 | 12 | 15 | 2 | — | — | 22 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 11 | 15 | 3 | — | — | 22 |
| Precursor t-cell lymphoblastic leukemia-lymphoma | D054218 | — | — | 4 | 8 | 5 | — | — | 13 |
| Philadelphia chromosome | D010677 | — | — | 1 | 7 | 3 | — | — | 11 |
Show 46 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Adenocarcinoma | D000230 | — | — | 3 | 17 | — | — | — | 19 |
| Recurrence | D012008 | — | — | 11 | 14 | — | — | — | 19 |
| Carcinoma | D002277 | — | C80.0 | 4 | 12 | — | — | — | 13 |
| Neoplasms | D009369 | — | C80 | 1 | 3 | — | — | — | 4 |
| Plasmablastic lymphoma | D000069293 | — | C83.3 | 3 | 2 | — | — | — | 3 |
| Large-cell lymphoma immunoblastic | D016400 | — | — | 3 | 2 | — | — | — | 3 |
| Hypersensitivity | D006967 | EFO_0003785 | T78.40 | — | 3 | — | — | — | 3 |
| Large-cell lymphoma anaplastic | D017728 | — | C84.6 | 2 | 3 | — | — | — | 3 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 1 | 1 | — | — | 1 | 3 |
| Skin neoplasms | D012878 | EFO_0004198 | C44 | 3 | 1 | — | — | — | 3 |
Show 84 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 10 | — | — | — | 1 | 11 |
| B-cell lymphoma marginal zone | D018442 | — | C88.4 | 2 | — | — | — | — | 2 |
| Obesity | D009765 | EFO_0001073 | E66.9 | 2 | — | — | — | — | 2 |
| Depression | D003863 | — | F33.9 | 1 | — | — | — | 1 | 2 |
| Non-small-cell lung carcinoma | D002289 | — | — | 1 | — | — | — | — | 1 |
| Colitis | D003092 | EFO_0003872 | K52.9 | 1 | — | — | — | — | 1 |
| Deltaretrovirus infections | D006800 | EFO_1001303 | — | 1 | — | — | — | — | 1 |
| Htlv-i infections | D015490 | EFO_0007316 | — | 1 | — | — | — | — | 1 |
| Aids-related lymphoma | D016483 | EFO_1001365 | — | 1 | — | — | — | — | 1 |
| Composite lymphoma | D058617 | — | — | 1 | — | — | — | — | 1 |
Show 7 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Heart failure | D006333 | EFO_0003144 | I50 | — | — | — | — | 5 | 5 |
| Giant cell arteritis | D013700 | EFO_1001209 | M31.6 | — | — | — | — | 3 | 3 |
| Polymyalgia rheumatica | D011111 | EFO_0008518 | M35.3 | — | — | — | — | 3 | 3 |
| Hip osteoarthritis | D015207 | EFO_1000786 | M16 | — | — | — | — | 3 | 3 |
| Cardiovascular diseases | D002318 | EFO_0000319 | I98 | — | — | — | — | 3 | 3 |
| Pituitary acth hypersecretion | D047748 | EFO_1001110 | E24.0 | — | — | — | — | 2 | 2 |
| Arthralgia | D018771 | — | M25.5 | — | — | — | — | 2 | 2 |
| Rotator cuff injuries | D000070636 | — | M75.1 | — | — | — | — | 2 | 2 |
| Acute coronary syndrome | D054058 | EFO_0005672 | — | — | — | — | — | 2 | 2 |
| Stroke | D020521 | EFO_0000712 | I63.9 | — | — | — | — | 2 | 2 |
Show 62 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Cort 108297 |
| INN | — |
| Description | — |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use